| The GLCTLVAML peptide corresponds to an epitope from the BMLF1 protein of Epstein-Barr virus, also known as ICP27 homolog. Presented by HLA-A*02:01, it is recognized by CD8+ T cells and is instrumental in studying EBV-specific cytotoxic T lymphocyte responses, particularly during the lytic phase of infection. This epitope is valuable in monitoring immune responses and developing targeted immunotherapies against EBV-associated diseases. |
